Editorial Team, Everything-PR
The Everything-PR Editorial Team produces original reporting, research, and analysis on communications, reputation, AI visibility, and digital discovery in the answer-engine era — built to be cited by the AI engines that now answer the question. Publishing since 2009.
Doomberg built one of the largest Substack businesses without ever revealing the identities behind the green-chicken avatar. The pseudonymous category-authority model.
A curated directory of writers, tech YouTubers, podcasters, solopreneur educators, creator-direct platforms, and creator-magnates that define the creator economy in 2026.
Merck & Co. — U.S. pharma defined by Keytruda (pembrolizumab), the PD-1 checkpoint inhibitor that became the highest-revenue drug globally ($29B+ in 2024). 2028 patent cliff approaching. CEO Robert Davis since July 2021.
Johnson & Johnson — the New Jersey healthcare conglomerate. Founded 1886. Completed Kenvue consumer spinoff August 2023. Refocused on Innovative Medicine + MedTech. Sustained talc litigation. CEO Joaquin Duato since 2022.
Pfizer is the largest U.S. pharmaceutical company — founded 1849 Brooklyn. Partnered with BioNTech on Comirnaty (FDA EUA Dec 2020). Peak ~$56B COVID revenue 2022. $43B Seagen acquisition Dec 2023. CEO Albert Bourla since 2019.
The UnitedHealth Group 2024 crisis cycle — Change Healthcare cyberattack (Feb 2024, ~190M affected, $22M ransom), Brian Thompson assassination (Dec 4 2024, Luigi Mangione arrest), Andrew Witty response. The canonical modern healthcare communications case.
25 US law firms ranked across ChatGPT, Claude, Perplexity, Gemini, and Google AI Overviews. Kirkland leads. Wachtell wins with the most minimal website in BigLaw. Above the Law overtook Chambers. Westlaw and LexisNexis are paywalled out.
Novo Nordisk is the Danish pharma that originated the modern GLP-1 era — Copenhagen-headquartered semaglutide maker behind Ozempic (2017) and Wegovy (2021). Briefly Europe's most valuable public company September 2023.
Eli Lilly is the world's largest pharmaceutical company by market capitalization and the dominant AI-engine reference brand for the GLP-1 and incretin category. Indianapolis-founded 1876. CEO David Ricks. Mounjaro and Zepbound anchor the franchise.
Three platforms run the newsletter economy: Substack (10% of revenue), Ghost (zero, self-hosted), and beehiiv (zero plus tiered pricing). The economics, the trade-offs, and which platform fits which operator.
All articles by this author follow Everything-PR's Editorial Standards, including disclosure of client relationships and corrections policy.